Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
218,988,928
-
Total 13F shares
-
20,397,061
-
Share change
-
+6,941,763
-
Total reported value
-
$132,786,813
-
Put/Call ratio
-
56%
-
Price per share
-
$6.51
-
Number of holders
-
62
-
Value change
-
+$45,673,710
-
Number of buys
-
31
-
Number of sells
-
20
Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q1 2018
As of 31 Mar 2018,
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,397,061 shares.
The largest 10 holders included
FMR LLC, SUMMER ROAD LLC, JENNISON ASSOCIATES LLC, Versant Venture Management, LLC, BlackRock Inc., SV Health Investors, LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, DELTEC ASSET MANAGEMENT LLC, and STATE STREET CORP.
This page lists
62
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.